Literature DB >> 31083780

Proposal for a chemically consistent way to annotate ions arising from the analysis of reference compounds under ESI conditions: A prerequisite to proper mass spectral database constitution in metabolomics.

Annelaure Damont1, Marie-Françoise Olivier1, Anna Warnet1, Bernard Lyan2, Estelle Pujos-Guillot2, Emilien L Jamin3, Laurent Debrauwer3, Stéphane Bernillon4, Christophe Junot1, Jean-Claude Tabet1,5, François Fenaille1.   

Abstract

Nowadays, high-resolution mass spectrometry is widely used for metabolomic studies. Thanks to its high sensitivity, it enables the detection of a large range of metabolites. In metabolomics, the continuous quest for a metabolite identification as complete and accurate as possible has led during the last decade to an ever increasing development of public MS databases (including LC-MS data) concomitantly with bioinformatic tool expansion. To facilitate the annotation process of MS profiles obtained from biological samples, but also to ease data sharing, exchange, and exploitation, the standardization and harmonization of the way to describe and annotate mass spectra seemed crucial to us. Indeed, under electrospray (ESI) conditions, a single metabolite does not produce a unique ion corresponding to its protonated or deprotonated form but could lead to a complex mixture of signals. These MS signals result from the existence of different natural isotopologues of the same compound and also to the potential formation of adduct ions, homomultimeric and heteromultimeric ions, fragment ions resulting from "prompt" in-source dissociations. As a joint reflection process within the French Infrastructure for Metabolomics and Fluxomics (MetaboHUB) and with the purpose of developing a robust and exchangeable annotated MS database made from pure reference compounds (chemical standards) analysis, it appeared to us that giving the metabolomics community some clues to standardize and unambiguously annotate each MS feature was a prerequisite to data entry and further efficient querying of the mass spectral database. The use of a harmonized notation is also mandatory for interlaboratory MS data exchange. Additionally, thorough description of the variety of MS signals arising from the analysis of a unique metabolite might provide greater confidence on its annotation.
© 2019 John Wiley & Sons, Ltd.

Keywords:  MS databases; annotation; high-resolution mass spectrometry; mass spectra; metabolomics

Mesh:

Year:  2019        PMID: 31083780     DOI: 10.1002/jms.4372

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  6 in total

1.  Improved Annotation of Untargeted Metabolomics Data through Buffer Modifications That Shift Adduct Mass and Intensity.

Authors:  Wenyun Lu; Xi Xing; Lin Wang; Li Chen; Sisi Zhang; Melanie R McReynolds; Joshua D Rabinowitz
Journal:  Anal Chem       Date:  2020-08-12       Impact factor: 6.986

2.  Combining Chemical Knowledge and Quantum Calculation for Interpreting Low-Energy Product Ion Spectra of Metabolite Adduct Ions: Sodiated Diterpene Diester Species as a Case Study.

Authors:  Jean-Claude Tabet; Yves Gimbert; Annelaure Damont; David Touboul; François Fenaille; Amina S Woods
Journal:  J Am Soc Mass Spectrom       Date:  2021-09-01       Impact factor: 3.109

3.  PeakForest: a multi-platform digital infrastructure for interoperable metabolite spectral data and metadata management.

Authors:  Nils Paulhe; Cécile Canlet; Annelaure Damont; Lindsay Peyriga; Stéphanie Durand; Catherine Deborde; Sandra Alves; Stephane Bernillon; Thierry Berton; Raphael Bir; Alyssa Bouville; Edern Cahoreau; Delphine Centeno; Robin Costantino; Laurent Debrauwer; Alexis Delabrière; Christophe Duperier; Sylvain Emery; Amelie Flandin; Ulli Hohenester; Daniel Jacob; Charlotte Joly; Cyril Jousse; Marie Lagree; Nadia Lamari; Marie Lefebvre; Claire Lopez-Piffet; Bernard Lyan; Mickael Maucourt; Carole Migne; Marie-Francoise Olivier; Estelle Rathahao-Paris; Pierre Petriacq; Julie Pinelli; Léa Roch; Pierrick Roger; Simon Roques; Jean-Claude Tabet; Marie Tremblay-Franco; Mounir Traïkia; Anna Warnet; Vanessa Zhendre; Dominique Rolin; Fabien Jourdan; Etienne Thévenot; Annick Moing; Emilien Jamin; François Fenaille; Christophe Junot; Estelle Pujos-Guillot; Franck Giacomoni
Journal:  Metabolomics       Date:  2022-06-14       Impact factor: 4.747

4.  Interlaboratory Comparison of Untargeted Mass Spectrometry Data Uncovers Underlying Causes for Variability.

Authors:  Trevor N Clark; Joëlle Houriet; Warren S Vidar; Joshua J Kellogg; Daniel A Todd; Nadja B Cech; Roger G Linington
Journal:  J Nat Prod       Date:  2021-03-05       Impact factor: 4.050

Review 5.  Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests.

Authors:  Florence Anne Castelli; Giulio Rosati; Christian Moguet; Celia Fuentes; Jose Marrugo-Ramírez; Thibaud Lefebvre; Hervé Volland; Arben Merkoçi; Stéphanie Simon; François Fenaille; Christophe Junot
Journal:  Anal Bioanal Chem       Date:  2021-08-25       Impact factor: 4.142

6.  Capillary Electrophoresis-Mass Spectrometry at Trial by Metabo-Ring: Effective Electrophoretic Mobility for Reproducible and Robust Compound Annotation.

Authors:  Nicolas Drouin; Marlien van Mever; Wei Zhang; Elena Tobolkina; Sabrina Ferre; Anne-Catherine Servais; Marie-Jia Gou; Laurent Nyssen; Marianne Fillet; Guinevere S M Lageveen-Kammeijer; Jan Nouta; Andrew J Chetwynd; Iseult Lynch; James A Thorn; Jens Meixner; Christopher Lößner; Myriam Taverna; Sylvie Liu; N Thuy Tran; Yannis Francois; Antony Lechner; Reine Nehmé; Ghassan Al Hamoui Dit Banni; Rouba Nasreddine; Cyril Colas; Herbert H Lindner; Klaus Faserl; Christian Neusüß; Manuel Nelke; Stefan Lämmerer; Catherine Perrin; Claudia Bich-Muracciole; Coral Barbas; Ángeles López Gonzálvez; Andras Guttman; Marton Szigeti; Philip Britz-McKibbin; Zachary Kroezen; Meera Shanmuganathan; Peter Nemes; Erika P Portero; Thomas Hankemeier; Santiago Codesido; Víctor González-Ruiz; Serge Rudaz; Rawi Ramautar
Journal:  Anal Chem       Date:  2020-10-01       Impact factor: 6.986

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.